Comparison of breast cancer survival in different age group: a multicentric database study in Penang, Malaysia
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This study compared breast cancer survival and the prognostic factors across different age groups of women in Penang, Malaysia. Data on 2,166 women with breast cancer who had been diagnosed between 2010 and 2014 were extracted from the Penang Breast Cancer Registry and stratified into 3 age groups: young (< 40 years old), middle-aged (40-59 years old), and elderly (≥ 60 years). The overall and relative survival rates were calculated using the life table method, median survival time was calculated using the Kaplan-Meier method, and comparisons between groups were conducted using the log-rank test. Prognostic factors were analyzed using a Cox proportional hazards model. The 5-year overall and breast cancer-specific survival rates for women with breast cancer in Penang were 72.9% and 75.2%, with a mean survival time of 92.5 months and 95.1 months, respectively. The 5-year breast cancer-specific survival rates for young, middle-aged, and elderly women were 74.9%, 77.8%, and 71.4%, respectively, with a mean survival time of 95.7 months, 97.5 months, and 91.2 months. There was a significant difference in breast cancer survival between age groups, with elderly women showing the lowest survival rate, followed by young and middle-aged women. Disease stage was the most prominent prognostic factor for all age groups. Survival rates and prognostic factors differed according to age group. Treatment planning for breast cancer patients should be age-specific to promote better cancer care and survival.
Abstract
This study compared breast cancer survival and the prognostic factors across different age groups of women in Penang, Malaysia. Data on 2,166 women with breast cancer who had been diagnosed between 2010 and 2014 were extracted from the Penang Breast Cancer Registry and stratified into 3 age groups: young (< 40 years old), middle-aged (40-59 years old), and elderly (≥ 60 years). The overall and relative survival rates were calculated using the life table method, median survival time was calculated using the Kaplan-Meier method, and comparisons between groups were conducted using the log-rank test. Prognostic factors were analyzed using a Cox proportional hazards model. The 5-year overall and breast cancer-specific survival rates for women with breast cancer in Penang were 72.9% and 75.2%, with a mean survival time of 92.5 months and 95.1 months, respectively. The 5-year breast cancer-specific survival rates for young, middle-aged, and elderly women were 74.9%, 77.8%, and 71.4%, respectively, with a mean survival time of 95.7 months, 97.5 months, and 91.2 months. There was a significant difference in breast cancer survival between age groups, with elderly women showing the lowest survival rate, followed by young and middle-aged women. Disease stage was the most prominent prognostic factor for all age groups. Survival rates and prognostic factors differed according to age group. Treatment planning for breast cancer patients should be age-specific to promote better cancer care and survival.
참고문헌 (30)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- "Malaysia national cancer registry report (MNCR) 2012-2016" (2017)[URL]
- "Malaysia- source:GLOBOCAN 2020"[URL]
- "Malaysian national cancer registry report 2007-2011" (2015)[URL]
- "Malaysian study on cancer survival (MySCan)" (2018)[URL]
- Nakamura K, "Characteristics and prognosis of Japanese female breast cancer patients : the BioBank Japan project", J Epidemiol, 27, pp.S58~S64 (2017)
- 이새별, "Chronological Improvement in Survival of Patients with Breast Cancer: A Large-Scale, Single-Center Study", Journal of Breast Cancer, 21(1), pp.70~79 (2018), 한국유방암학회[DOI]
- "Singapore cancer registry annual registry report 2015" (2017)[URL]
- Hanis TM, "Modelling excess mortality among breast cancer patients in the north east region of peninsular Malaysia, 2007-2011 : a population-based study", BMC Public Health, 19, pp.1754~ (2019)
- Abdullah NA, "Survival rate of breast cancer patients in Malaysia : a population-based study", Asian Pac J Cancer Prev, 14, pp.4591~4594 (2013)
- Nordin N, "Survival time and prognostic factors for breast cancer among women in north-east peninsular Malaysia", Asian Pac J Cancer Prev, 19, pp.497~502 (2018)
- "ePeta public" (2020)[URL]
- "File: Malaysia, administrative divisions -de - colored.svg"[URL]
- "Current population estimates Malaysia" (2018)[URL]
- Pathy NB, "Breast cancer in a multi-ethnic Asian setting : results from the Singapore-Malaysia hospital-based breast cancer registry", Breast, 20(Suppl 2), pp.S75~S80 (2011)
- Yip CH, "Epidemiology of breast cancer in Malaysia", Asian Pac J Cancer Prev, 7, pp.369~374 (2006)
- Ibrahim NI, "Who are the breast cancer survivors in Malaysia?", Asian Pac J Cancer Prev, 13, pp.2213~2218 (2012)
- Samane Nematolahi, "A comparison of breast cancer survival among young, middle-aged, and elderly patients in southern Iran using Cox and empirical Bayesian additive hazard models", Epidemiology and Health, 39, pp.1~7 (2017), 한국역학회[DOI]
- Bhoo-Pathy N, "Ethnic differences in survival after breast cancer in South East Asia", PLoS One, 7, pp.e30995~ (2012)
- Mohd Mujar NM, "Complementary and alternative medicine(CAM)use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia", PLoS One, 12, pp.e0176394~ (2017)
- Taib NA, "Improvement in survival of breast cancer patients-trends over two time periods in a single institution in an Asia Pacific country, Malaysia", Asian Pac J Cancer Prev, 12, pp.345~349 (2011)
- Cheng ML, "Factors influencing late stage of breast cancer at presentation in a district Hospital-Segamat Hospital, Johor", Med J Malaysia, 70, pp.148~152 (2015)
- Zangouri V MD, "Medullary breast carcinoma and invasive ductal carcinoma : a review study", Iran J Med Sci, 43, pp.365~371 (2018)
- Wang XX, "Difference in characteristics and outcomes between medullary breast carcinoma and invasive ductal carcinoma : a population based study from SEER 18 database", Oncotarget, 7, pp.22665~22673 (2016)
- 박인혜, "Comparison of the Characteristics of Medullary Breast Carcinoma and Invasive Ductal Carcinoma", Journal of Breast Cancer, 16(4), pp.417~425 (2013), 한국유방암학회
- Li CI, "Risk of mortality by histologic type of breast cancer in the United States", Horm Cancer, 1, pp.156~165 (2010)
- Flucke U, "Distinguishing medullary carcinoma of the breast from highgrade hormone receptor-negative invasive ductal carcinoma : an immunohistochemical approach", Histopathology, 56, pp.852~859 (2010)
- Cao AY, "Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China : a comparison with infiltrating ductal carcinoma-not otherwise specified", World J Surg Oncol, 11, pp.91~ (2013)
- Early Breast Cancer Trialists’ Collaborative Group(EBCTCG), "Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival : an overview of the randomised trials", Lancet, 365, pp.1687~1717 (2005)
- Smith TJ, "Review : chemotherapy and hormonal therapy reduce recurrence and mortality at 15 years in early breast cancer", ACP J Club, 143, pp.58~ (2005)